Integra LifeSciences Holdings Balance Sheet Health
Financial Health criteria checks 2/6
Integra LifeSciences Holdings has a total shareholder equity of $1.5B and total debt of $1.8B, which brings its debt-to-equity ratio to 118.9%. Its total assets and total liabilities are $4.1B and $2.5B respectively. Integra LifeSciences Holdings's EBIT is $193.9M making its interest coverage ratio 4.2. It has cash and short-term investments of $277.6M.
Key information
118.9%
Debt to equity ratio
US$1.81b
Debt
| Interest coverage ratio | 4.2x |
| Cash | US$277.60m |
| Equity | US$1.52b |
| Total liabilities | US$2.54b |
| Total assets | US$4.07b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IL3's short term assets ($1.1B) exceed its short term liabilities ($912.6M).
Long Term Liabilities: IL3's short term assets ($1.1B) do not cover its long term liabilities ($1.6B).
Debt to Equity History and Analysis
Debt Level: IL3's net debt to equity ratio (100.6%) is considered high.
Reducing Debt: IL3's debt to equity ratio has increased from 107.3% to 118.9% over the past 5 years.
Debt Coverage: IL3's debt is not well covered by operating cash flow (7.6%).
Interest Coverage: IL3's interest payments on its debt are well covered by EBIT (4.2x coverage).